Literature DB >> 23939886

Multilocus sequence typing reveals genetic diversity of carbapenem- or ceftazidime-nonsusceptible Pseudomonas aeruginosa in China.

Jingshu Ji1, Jie Wang, Zhihui Zhou, Haiping Wang, Yan Jiang, Yunsong Yu.   

Abstract

It is unclear whether the genetic background of drug-resistant Pseudomonas aeruginosa was disseminated from a certain clone. Thus, we performed MLST (multilocus sequence typing) of 896 P. aeruginosa isolates that were nonsusceptible to imipenem, meropenem, or ceftazidime. This revealed 254 sequence types (STs), including 104 new STs and 34 STs with novel alleles. Thirty-three clonal complexes and 404 singletons were found. In conclusion, drug-resistant P. aeruginosa clones can be developed from diverse genetic backgrounds.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23939886      PMCID： PMC3811290          DOI： 10.1128/AAC.00970-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates.

Authors:  Nurul Huda Khan; Yoshikazu Ishii; Noriko Kimata-Kino; Hidetake Esaki; Tomohiko Nishino; Masahiko Nishimura; Kazuhiro Kogure
Journal:  Microb Ecol       Date:  2007-02       Impact factor: 4.552

2.  Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase.

Authors:  Laura Pagani; Céline Colinon; Roberta Migliavacca; Maria Labonia; Jean-Denis Docquier; Elisabetta Nucleo; Melissa Spalla; Michele Li Bergoli; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002.

Authors:  Hui Wang; Minjun Chen
Journal:  Diagn Microbiol Infect Dis       Date:  2005-03       Impact factor: 2.803

4.  Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa.

Authors:  Barry Curran; Daniel Jonas; Hajo Grundmann; Tyrone Pitt; Christopher G Dowson
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

5.  Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river.

Authors:  Jean-Paul Pirnay; Sandra Matthijs; Huri Colak; Patrice Chablain; Florence Bilocq; Johan Van Eldere; Daniel De Vos; Martin Zizi; Ludwig Triest; Pierre Cornelis
Journal:  Environ Microbiol       Date:  2005-07       Impact factor: 5.491

Review 6.  Pathophysiology and management of pulmonary infections in cystic fibrosis.

Authors:  Ronald L Gibson; Jane L Burns; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2003-10-15       Impact factor: 21.405

7.  Population structure of Pseudomonas aeruginosa.

Authors:  Lutz Wiehlmann; Gerd Wagner; Nina Cramer; Benny Siebert; Peter Gudowius; Gracia Morales; Thilo Köhler; Christian van Delden; Christian Weinel; Peter Slickers; Burkhard Tümmler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-27       Impact factor: 11.205

8.  Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex.

Authors:  Joanna Empel; Krzysztof Filczak; Agnieszka Mrówka; Waleria Hryniewicz; David M Livermore; Marek Gniadkowski
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

Review 9.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

10.  Pseudomonas aeruginosa population structure revisited.

Authors:  Jean-Paul Pirnay; Florence Bilocq; Bruno Pot; Pierre Cornelis; Martin Zizi; Johan Van Eldere; Pieter Deschaght; Mario Vaneechoutte; Serge Jennes; Tyrone Pitt; Daniel De Vos
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240
View more
  6 in total

1.  Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia.

Authors:  Johanna M Vanegas; Astrid V Cienfuegos; Ana M Ocampo; Lucelly López; Helena del Corral; Gustavo Roncancio; Patricia Sierra; Lina Echeverri-Toro; Sigifredo Ospina; Natalia Maldonado; Carlos Robledo; Andrea Restrepo; J Natalia Jiménez
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

2.  Antibiotic-Resistant Bacteria in Clams-A Study on Mussels in the River Rhine.

Authors:  Nicole Zacharias; Iris Löckener; Sarah M Essert; Esther Sib; Gabriele Bierbaum; Thomas Kistemann; Christiane Schreiber
Journal:  Antibiotics (Basel)       Date:  2021-05-12

3.  Diverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in Kunming.

Authors:  Xin Fan; Yue Wu; Meng Xiao; Zhi-Peng Xu; Timothy Kudinha; Alda Bazaj; Fanrong Kong; Ying-Chun Xu
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

4.  Multilocus sequence typing and variations in the oprD gene of Pseudomonas aeruginosa isolated from a hospital in China.

Authors:  Huiqin Liu; Weina Kong; Weina Yang; Gukui Chen; Haihua Liang; Yani Zhang
Journal:  Infect Drug Resist       Date:  2018-01-08       Impact factor: 4.003

5.  Molecular Typing and Carbapenem Resistance Mechanisms of Pseudomonas aeruginosa Isolated From a Chinese Burn Center From 2011 to 2016.

Authors:  Supeng Yin; Ping Chen; Bo You; Yulong Zhang; Bei Jiang; Guangtao Huang; Zichen Yang; Yu Chen; Jing Chen; Zhiqiang Yuan; Yan Zhao; Ming Li; Fuquan Hu; Yali Gong; Yizhi Peng
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

6.  Emergence of Carbapenem-Resistant ST244, ST292, and ST2446 Pseudomonas aeruginosa Clones in Burn Patients in Yunnan Province.

Authors:  Yue Fang; Zulqarnain Baloch; Wei Zhang; Ying Hu; Rui Zheng; Yuzhu Song; Wenlin Tai; Xueshan Xia
Journal:  Infect Drug Resist       Date:  2022-03-16       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.